No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): Evidence from a non-randomised retrospective study

Journal of Neural Transmission

Volumn 115, Issue 2, 2008, Pages 335-339

  Huss, M ^a   Poustka, F ^b   Lehmkuhl, G ^c   Lehmkuhl, U ^d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

(ADHD) substance use disorder; Attention deficit hyperactivity disorder; Long term outcome; Methylphenidate; Nicotine dependency

Indexed keywords

METHYLPHENIDATE; NICOTINE;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CIGARETTE SMOKING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HUMAN; LOG RANK TEST; LONG TERM RISK; MAJOR CLINICAL STUDY; MALE; NICOTINE USE DISORDER; ONSET AGE; PRIORITY JOURNAL; SURVIVAL; TREATMENT DURATION; URINALYSIS;

AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOBACCO USE DISORDER;

EID: 39549088100     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0872-3     Document Type: Article

References (21)

1. J Biederman 2003 Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD J Clin Psychiatry 64 Suppl 11 3 8
2. J Biederman T Wilens E Mick S Faraone W Weber S Curtis A Thornell K Pfister J Jetton J Soriano 1997 Is ADHD a risk factor for psychoactive substance use disorders? findings from a four-year prospective follow-up study J Am Acad Child Adolesc Psychiatry 36 21 29
3. Borenstein M, Rothstein H, Cohen J (1997) Sample power. Version 1.20. SPSS Inc.
4. S Curran S Newman E Taylor P Asherson 2000 Hypescheme: an operational criteria checklist and minimum data set for molecular genetic studies of attention deficit and hyperactivity disorders Am J Med Genet 96 244 250
5. IJ Elkins M McGue WG Iacono 2007 Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse Arch Gen Psychiat 64 1145 1152
6. SM Gordon F Tulak J Troncale 2004 Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence J Addict Dis 23 31 40
7. Huss M (2007) Long-term effects of methylphenidate treatment on the development of substance use disorders in children with attention-deficit- hyperactivity disorder (ADHD) [habilitation]. Charité Berlin. 141 pp
8. Huss M, Schmidt-Schulz A, Mendes U, Völger M, Lehmkuhl U (1998) Discriminant power of a new diagnostic tool for retrospective analysis of ADHD. Conference Proceeding IACAPAP Stockholm
9. M Huss U Lehmkuhl 2002 Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies J Atten Disord 6 Suppl 1 S65 S71
10. M Jessup 1996 Nicotine: a gateway drug? J Am Med Women Assoc 51 21
11. NM Lambert CS Hartsough 1998 Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants J Learn Disabil 31 533 544
12. GB Lindsay J Rainey 1997 Psychosocial and pharmacologic explanations of nicotine's "gateway drug" function J Sch Health 67 123 126
13. BS Molina WE Pelham 2003 Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD J Abnorm Psychol 112 497 507
14. MC Monuteaux TJ Spencer SV Faraone AM Wilson J Biederman 2007 A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder J Clin Psychiatry 68 1094 1101
15. U Preuss SJ Ralston G Baldursson B Falissard MJ Lorenzo R Rodrigues Pereira L Vlasveld D Coghill the ADORE study group 2006 Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study Eur Child Adolesc Psychiatry 15 Suppl 1 4 14
16. TW Robbins 2002 ADHD and addiction Nat Med 8 24 25
17. L Robins J Wing H Wittchen J Helzer T Babor J Burke A Farmer A Jablenski R Pickens D Regier 1988 The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures Arch Gen Psychiat 45 1069 1077
18. CM Szobot LA Rohde O Bukstein BS Molina C Martins P Ruaro F Pechansky 2007 Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study Addiction 102 1122 1130
19. TE Wilens 2004 Impact of ADHD and its treatment on substance abuse in adults J Clin Psychiatry 65 Suppl 3 38 45
20. TE Wilens J Adamson S Sgambati J Whitley A Santry MC Monuteaux J Biederman 2007 Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD Am J Addict 16 Suppl 1 14 21
21. TE Wilens SV Faraone J Biederman S Gunawardene 2003 Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature Pediatrics 111 179 185